US2009053728A1PendingUtilityA1

Analytical Method and Kit

71
Assignee: SECR DEFENCEPriority: May 9, 2001Filed: Nov 3, 2008Published: Feb 26, 2009
Est. expiryMay 9, 2021(expired)· nominal 20-yr term from priority
C12Q 1/68C12Q 1/686C12Q 1/6874
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Analytical methods using RNA probes for the detection or analysis of nucleic acid sequences is described. These probes are contacted with a sample suspected of containing the nucleic acid sequence and if they form duplexes, they are hydrolysed. This may be done, for example during an amplification reaction. AMP generated as a result of the hydrolysis is converted to ATP. The ATP may then be detected using bioluminescent reagents.

Claims

exact text as granted — not AI-modified
1 - 35 . (canceled) 
   
   
       36 . A method for detecting the presence or amount of a target nucleic acid within a sample, said method comprising denaturing nucleic acids within the sample; contacting these nucleic acids with an RNA hydrolysis probe which is specific for at least a portion of said target nucleic acid so that the probe forms duplexes with the target nucleic acid; adding an RNAse enzyme which hydrolyses RNA only when in double stranded form and one or more enzymes or reagents necessary to convert adenosine monophosphate produced to adenosine triphosphate; adding to the sample bioluminescent reagents which react to the presence of ATP; detecting a signal from said bioluminescent reagents; and, relating that signal to the presence or amount of the target nucleic acid sequence. 
   
   
       37 . The method of  claim 36 , wherein the one or more enzymes or reagents necessary to convert adenosine monophosphate to adenosine triphosphate comprises
 a) phosphoenolpyruvate synthase, phosphate and phosphoenlpyruvate; and/or   b) nucleoside triphosphate-adenylate kinase, nucleoside 5′-triphosphate (NTP) and adenylate kinase; and/or   c) pyruvate phosphate dikinase.   
   
   
       38 . The method of  claim 36 , wherein the bioluminescent reagents comprise luciferin and luciferase. 
   
   
       39 . The method of  claim 36 , wherein the bioluminescent reagents further comprise a source of magnesium ions. 
   
   
       40 . The method of  claim 36 , further comprising conducting an amplification reaction, wherein the target nucleic acid is DNA and the reaction is conducted in the presence of a DNA polymerase. 
   
   
       41 . The method of  claim 40 , wherein the bioluminescent reagents are present or added throughout the amplification reaction. 
   
   
       42 . A method for determining the sequence of a nucleic acid, said method comprising
 a) binding an RNA probe to a known region of said sequence such that at least one nucleotide at an end of said probe reaches into an unknown or uncertain region of the sequence;   b) hydrolysing the RNA probe using an RNAse enzyme which hydrolyses RNA only when in double stranded form;   c) converting adenosine monophosphate produced to adenosine triphosphate;   d) adding to the sample bioluminescent reagents which react to the presence of ATP;   e) detecting a signal from said bioluminescent reagents; and   f) relating that signal to the presence of a region of the sequence which is complementary or otherwise to the end of the probe.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.